Association of cabozantinib residual concentration (Ctrough) and blood clearance (Cl/F) with toxicity (tox) and progressive disease (PD) in metastatic renal cell carcinoma (mRCC) patients (pts): Results from a monocentric pharmacokinetics (PK) study.

被引：0
|
作者：
Cerbone, Luigi [1 ]
Combarel, David [2 ]
Foulon, Stephanie [2 ]
Geraud, Arthur [3 ]
Alves, Carolina [4 ]
Colomba, Emeline [5 ]
Carril, Lucia [6 ]
Derosa, Lisa [7 ]
Flippot, Ronan
Mir, Olivier [8 ]
Escudier, Bernard [9 ]
Paci, Angelo [4 ]
Albiges, Laurence [10 ]
机构：
[1] Gustave Roussy, Dept Med Oncol, Villejuif, France
[2] Inst Gustave Roussy, Villejuif, France
[3] Gustave Roussy, Paris, France
[4] Gustave Roussy Canc Campus, Villejuif, France
[5] Univ Paris Saclay, Gustave Roussy Canc Campus, Paris, France
[6] Hosp 12 Octubre, Madrid, Spain
[7] Paris Saclay Univ, Gustave Roussy Canc Campus, U1015 INSERM, Villejuif, France
[8] Gustave Roussy Canc Inst, Villejuif, France
[9] Gustave Roussy, Villejuif, France
[10] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期
关键词：
D O I：
10.1200/JCO.2021.39.6_suppl.292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
292
引用
收藏
页数：2
相关论文
共 3 条
  • [1] Cabozantinib (Cabo) concentration (Cmin) association with toxicity (tox) and treatment failure in metastatic renal cell carcinoma (mRCC) patients: The MONICA study
    Cerbone, L.
    Combarel, D.
    Geraud, A.
    Foulon, S.
    Silva, Carolina Alves Costa
    Colomba-Blameble, E.
    Derosa, L.
    Guida, A.
    Flippot, R.
    Carril-Ajuria, L.
    Mir, O.
    Escudier, B.
    Paci, A.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S569 - S570
  • [2] Association of cabozantinib pharmacokinetics, progression and toxicity in metastatic renal cell carcinoma patients: results from a pharmacokinetics/pharmacodynamics study
    Cerbone, L.
    Combarel, D.
    Geraud, A.
    Auclin, E.
    Foulon, S.
    Silva, C. Alves Costa
    Colomba, E.
    Carril, L.
    Derosa, L.
    Flippot, R.
    Mir, O.
    Khoudour, N.
    Blanchet, B.
    Escudier, B.
    Paci, A.
    Albiges, L.
    ESMO OPEN, 2021, 6 (06)
  • [3] Evaluation of PBRM1, PD-L1, CD31, and CD4/CD8 ratio as a predictive signature of response to VEGFR-TKI-based therapy in patients with metastatic renal cell carcinoma (mRCC) with IMDC intermediate prognosis: Results from the APAChE-I Study.
    Ciccarese, Chiara
    Buti, Sebastiano
    Roberto, Michela
    Calabro, Fabio
    Masini, Cristina
    Massari, Francesco
    Cannella, Maria Antonella
    Mazzaschi, Giulia
    Astore, Serena
    Di Girolamo, Stefania
    Panebianco, Martina
    Mollica, Veronica
    Granitto, Alessia
    Fiorentino, Vincenzo
    Pierconti, Francesco
    Martini, Maurizio
    Porta, Camillo
    Tortora, Giampaolo
    Iacovelli, Roberto
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
1